Intuitive Surgical Gets Price Target Bumps By Analysts After Better-Than-Expected Q1 Results

Intuitive Surgical, Inc. ISRG reported better-than-expected Q1 results.

Intuitive Surgical posted adjusted earnings of $1.23 per share, beating analysts’ estimates of $1.20 per share. The company’s sales came in at $1.70 billion, versus expectations of $1.59 billion.

Intuitive Surgical shares rose 11.4% to trade at $299.99 on Wednesday

These analysts made changes to their price targets on Intuitive Surgical following earnings announcement.

• Citigroup raised the price target on Intuitive Surgical from $305 to $317. Citigroup analyst Joanne Wuensch maintained the stock with a Buy.
• Raymond James raised the price target on Intuitive Surgical from $270 to $323. Raymond James analyst Jason Bednar maintained an Outperform rating.
• Wells Fargo raised the price target on Intuitive Surgical from $289 to $310. Wells Fargo analyst Larry Biegelsen maintained the stock with an Overweight rating.
• Mizuho increased the price target on Intuitive Surgical from $250 to $300. Mizuho analyst Anthony Petrone maintained the stock with a Neutral.
• B of A Securities raised the price target on Intuitive Surgical from $300 to $315. B of A Securities analyst Travis Steed maintained the stock with a Buy.
• Truist Securities boosted the price target on Intuitive Surgical from $300 to $325. Truist Securities analyst Richard Newitter maintained a Buy rating on the stock.
• Morgan Stanley raised the price target from $265 to $285. Morgan Stanley analyst Cecilia Furlong maintained Intuitive Surgical with an Equal-Weight.
• RBC Capital boosted the price target on the stock from $305 to $309. RBC Capital analyst Shagun Singh maintained Intuitive Surgical with an Outperform.
• JP Morgan increased the price target on the stock from $250 to $335. JP Morgan analyst Robbie Marcus maintained Intuitive Surgical with an Overweight rating.

Read More: Investor Optimism Declines Following Earnings Reports